Disclosures for "Assessing Optic Nerve Involvement in Multiple Sclerosis With and Without History of Optic Neuritis Using OCT and MRI"
-
Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
-
Dr. Gualco has nothing to disclose.
-
Mr. Boffa has nothing to disclose.
-
Dr. Razzetta has nothing to disclose.
-
Dr. Garbarino has nothing to disclose.
-
Maria Cellerino has nothing to disclose.